The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 122: 1639-1642.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abb, J.
Right arrow Articles by Deinhardt, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Abb, J.
Right arrow Articles by Deinhardt, F.

Lymphocyte Activation by the Tumor-Promoting Agent 12-O-Tetradecanoylphorbol-13-Acetate (TPA)1

Jochen Abb, Gary J. Bayliss and Friedrich Deinhardt

From the Max von Pettenkofer Institute of Hygiene and Medical Microbiology, Pettenkoferstrasse 9a, D-8000 Munich 2, Federal Republic of Germany

Abstract

TPA, a highly active tumor-promoting agent, is an effective mitogen for primate peripheral blood lymphocytes. Optimal stimulation of human lymphocytes was obtained 4 days after the addition of TPA at a concentration of 7.5 ng/ml. Lymphocyte fractionation experiments demonstrated that both T and B cells incorporated 3H-thymidine significantly in response to TPA. Lymphocyte blastogenesis was not due to the reactivation of latent herpesviruses by the tumor promoter, since similar responses to TPA were obtained with virus-genome positive or negative cells. Increased levels of DNA synthesis were observed when TPA was added to marmoset, baboon, rhesus monkey, or chimpanzee peripheral blood lymphocytes. Canine peripheral blood lymphocytes and spleen cells from guinea pigs, rats, and mice were not stimulated by TPA. These observations suggest that TPA-induced lymphocyte blastogenesis may be useful for studies of lymphocyte activation and of the molecular mechanisms of action of tumor-promoting phorbol esters.

Footnotes

1 This work has been supported by Deutsche Forschungsgemeinschaft, SFB 37, G 7, and Wo. 227/2.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Gorelik, J. Y. Fang, A. Wu, A. H. Sawalha, and B. Richardson
Impaired T Cell Protein Kinase C{delta} Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus
J. Immunol., October 15, 2007; 179(8): 5553 - 5563.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ertesvag, N. Engedal, S. Naderi, and H. K. Blomhoff
Retinoic Acid Stimulates the Cell Cycle Machinery in Normal T Cells: Involvement of Retinoic Acid Receptor-Mediated IL-2 Secretion
J. Immunol., November 15, 2002; 169(10): 5555 - 5563.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. A. Davis, A. A. Saini, P. J. Blair, B. L. Levine, N. Craighead, D. M. Harlan, C. H. June, and K. P. Lee
Phorbol Esters Induce Differentiation of Human CD34+ Hemopoietic Progenitors to Dendritic Cells: Evidence for Protein Kinase C-Mediated Signaling
J. Immunol., April 15, 1998; 160(8): 3689 - 3697.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Weinberg
Tumor cell killing by phorbol ester--differentiated human leukemia cells
Science, August 7, 1981; 213(4508): 655 - 657.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.